Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124674833 | 12467483 | 3 | F | 20160720 | 20160615 | 20160726 | PER | PHEH2016US014506 | NOVARTIS | 0.00 | F | Y | 0.00000 | 20160726 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124674833 | 12467483 | 1 | PS | VIVELLE-DOT | ESTRADIOL | 1 | Transdermal | 0.037 MG, UNK | U | 76812 | 20538 | .037 | MG | TRANS-THERAPEUTIC-SYSTEM | |||||
| 124674833 | 12467483 | 2 | SS | ESTRADIOL. | ESTRADIOL | 1 | Transdermal | U | 0 | PATCH | |||||||||
| 124674833 | 12467483 | 3 | C | PROTONIX//PANTOPRAZOLE SODIUM SESQUIHYDRATE | 2 | Unknown | 40 MG, UNK | U | 0 | 40 | MG | ||||||||
| 124674833 | 12467483 | 4 | C | VITAMIN D | CHOLECALCIFEROL | 1 | Unknown | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124674833 | 12467483 | 1 | Product used for unknown indication |
| 124674833 | 12467483 | 2 | Product used for unknown indication |
| 124674833 | 12467483 | 3 | Product used for unknown indication |
| 124674833 | 12467483 | 4 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124674833 | 12467483 | Product adhesion issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |